Regulation of gene transcription by the oncoprotein MYC

Gene

Volumn 494, Issue 2, 2012, Pages 145-160

  Lüscher, Bernhard ^a   Vervoorts, Jörg ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Acetylation; Chromatin; Methylation; Post translational modification; Transformation; Ubiquitination

Indexed keywords

HISTONE; HISTONE ACETYLTRANSFERASE; MYC PROTEIN; ONCOPROTEIN; PROTEIN P300; PROTEIN P53;

ACETYLATION; APOPTOSIS; BINDING SITE; BIOCHEMISTRY; BIOSYNTHESIS; CELL PROLIFERATION; CHROMATIN; ENERGY METABOLISM; GENE CONTROL; GENE EXPRESSION; GENE REPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HISTONE METHYLATION; HUMAN; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA PROCESSING; UBIQUITINATION;

ACETYLATION; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-MYC; UBIQUITINATION;

EID: 84856338151     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2011.12.027     Document Type: Review

References (239)

1. Adhikary S., et al. The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation. Cell 2005, 123:409-421.
2. Agrawal P., Yu K., Salomon A.R., Sedivy J.M. Proteomic profiling of Myc-associated proteins. Cell Cycle 2010, 9:4908-4921.
3. Alland L., et al. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 1997, 387:49-55.
4. Allard S., et al. NuA4, an essential transcription adaptor/histone H4 acetyltransferase complex containing Esa1p and the ATM-related cofactor Tra1p. EMBO J. 1999, 18:5108-5119.
5. Amati B., Brooks M.W., Levy N., Littlewood T.D., Evan G.I., Land H. Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell 1993, 72:233-245.
6. Amati B., Littlewood T.D., Evan G.I., Land H. The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J. 1993, 12:5083-5087.
7. Amente S., Bertoni A., Morano A., Lania L., Avvedimento E.V., Majello B. LSD1-mediated demethylation of histone H3 lysine 4 triggers Myc-induced transcription. Oncogene 2010, 29:3691-3702.
8. Arabi A., et al. c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription. Nat Cell Biol. 2005, 7:303-310.
9. Austen M., Cerni C., Luscher-Firzlaff J.M., Lüscher B. YY1 can inhibit c-Myc function through a mechanism requiring DNA binding of YY1 but neither its transactivation domain nor direct interaction with c-Myc. Oncogene 1998, 17:511-520.
10. Awasthi S., et al. A human T-cell lymphotropic virus type 1 enhancer of Myc transforming potential stabilizes Myc-TIP60 transcriptional interactions. Mol. Cell. Biol. 2005, 25:6178-6198.
11. Bajaj B.G., Murakami M., Cai Q., Verma S.C., Lan K., Robertson E.S. Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein. J. Virol. 2008, 82:4082-4090.
12. Baker S.P., Grant P.A. The SAGA continues: expanding the cellular role of a transcriptional co-activator complex. Oncogene 2007, 26:5329-5340.
13. Bedford D.C., Kasper L.H., Fukuyama T., Brindle P.K. Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases. Epigenetics 2010, 5:9-15.
14. Bentley D.L. Rules of engagement: co-transcriptional recruitment of pre-mRNA processing factors. Curr. Opin. Cell Biol. 2005, 17:251-256.
15. Berberich S.J., Cole M.D. Casein kinase II inhibits the DNA-binding activity of Max homodimers but not Myc/Max heterodimers. Genes Dev. 1992, 6:166-176.
16. Bernassola F., Karin M., Ciechanover A., Melino G. The HECT family of E3 ubiquitin ligases: multiple players in cancer development. Cancer Cell 2008, 14:10-21.
17. Bieda M., Xu X., Singer M.A., Green R., Farnham P.J. Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome. Genome Res. 2006, 16:595-605.
18. Blackwood E.M., Eisenman R.N. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 1991, 251:1211-1217.
19. Blackwood E.M., Lüscher B., Eisenman R.N. Myc and Max associate in vivo. Genes Dev. 1992, 6:71-80.
20. Bonetti P., Davoli T., Sironi C., Amati B., Pelicci P.G., Colombo E. Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7 gamma. J. Cell Biol. 2008, 182:19-26.
21. Boone D.N., Qi Y., Li Z., Hann S.R. Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:632-637.
22. Bouchard C., et al. Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. Genes Dev. 2001, 15:2042-2047.
23. Bouchard C., Marquardt J., Bras A., Medema R.H., Eilers M. Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins. EMBO J. 2004, 23:2830-2840.
24. Bousset K., Henriksson M., Luscher-Firzlaff J.M., Litchfield D.W., Lüscher B. Identification of casein kinase II phosphorylation sites in Max: effects on DNA-binding kinetics of Max homo- and Myc/Max heterodimers. Oncogene 1993, 8:3211-3220.
25. Brenner C., et al. Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO J. 2005, 24:336-346.
26. Bres V., Yoh S.M., Jones K.A. The multi-tasking P-TEFb complex. Curr. Opin. Cell Biol. 2008, 20:334-340.
27. Bres V., Yoshida T., Pickle L., Jones K.A. SKIP interacts with c-Myc and Menin to promote HIV-1 Tat transactivation. Mol. Cell. 2009, 36:75-87.
28. Bretones G., et al. SKP2 oncogene is a direct MYC target gene and MYC down-regulates p27(KIP1) through SKP2 in human leukemia cells. J. Biol. Chem. 2011, 286:9815-9825.
29. Buratowski S. Progression through the RNA polymerase II CTD cycle. Molecular cell. 2009, 36:541-546.
30. Caron C., et al. Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers. Oncogene 2010, 29:5171-5181.
31. Chan C.H., et al. Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis. Nat. Cell Biol. 2010, 12:457-467.
32. Chang T.C., et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat. Genet. 2008, 40:43-50.
33. Chen D., Kon N., Li M., Zhang W., Qin J., Gu W. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor. Cell 2005, 121:1071-1083.
34. Chen Y., Blackwell T.W., Chen J., Gao J., Lee A.W., States D.J. Integration of genome and chromatin structure with gene expression profiles to predict c-MYC recognition site binding and function. PLoS Comput. Biol. 2007, 3:e63.
35. Chen X., et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008, 133:1106-1117.
36. Cheng S.W., Davies K.P., Yung E., Beltran R.J., Yu J., Kalpana G.V. c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function. Nat. Genet. 1999, 22:102-105.
37. Cheng A.S., et al. Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters. Molecular cell. 2006, 21:393-404.
38. Choi S.H., Wright J.B., Gerber S.A., Cole M.D. Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cells. Genes Dev. 2010, 24:1236-1241.
39. Ciro M., et al. ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors. Cancer Res. 2009, 69:8491-8498.
40. Cole M.D., Cowling V.H. Specific regulation of mRNA cap methylation by the c-Myc and E2F1 transcription factors. Oncogene 2009, 28:1169-1175.
41. Cole M.D., Nikiforov M.A. Transcriptional activation by the Myc oncoprotein. Curr. Top. Microbiol. Immunol. 2006, 302:33-50.
42. Comino-Mendez I., et al. Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat. Genet. 2011, 43:663-667.
43. Core L.J., Lis J.T. Transcription regulation through promoter-proximal pausing of RNA polymerase II. Science 2008, 319:1791-1792.
44. Cotterman R., Knoepfler P.S. N-Myc regulates expression of pluripotency genes in neuroblastoma including lif, klf2, klf4, and lin28b. PLoS One 2009, 4:e5799.
45. Cotterman R., et al. N-Myc regulates a widespread euchromatic program in the human genome partially independent of its role as a classical transcription factor. Cancer Res. 2008, 68:9654-9662.
46. Cowling V.H., Cole M.D. The Myc transactivation domain promotes global phosphorylation of the RNA polymerase II carboxy-terminal domain independently of direct DNA binding. Mol. Cell. Biol. 2007, 27:2059-2073.
47. Cowling V.H., Cole M.D. Myc regulation of mRNA Cap methylation. Genes & Cancer 2010, 1:576-579.
48. Dai M.S., Arnold H., Sun X.X., Sears R., Lu H. Inhibition of c-Myc activity by ribosomal protein L11. EMBO J. 2007, 26:3332-3345.
49. Dai M.S., Sun X.X., Lu H. Ribosomal protein L11 associates with c-Myc at 5 S rRNA and tRNA genes and regulates their expression. J. Biol. Chem. 2010, 285:12587-12594.
50. Dang C.V. Therapeutic targeting of Myc-reprogrammed cancer cell metabolism. Cold Spring Harbor symposia on quantitative biology 2011.
51. Datta A., et al. Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc. J. Biol. Chem. 2004, 279:36698-36707.
52. de Nigris F., Botti C., Rossiello R., Crimi E., Sica V., Napoli C. Cooperation between Myc and YY1 provides novel silencing transcriptional targets of alpha3beta1-integrin in tumour cells. Oncogene 2007, 26:382-394.
53. Deleu L., Shellard S., Alevizopoulos K., Amati B., Land H. Recruitment of TRRAP required for oncogenic transformation by E1A. Oncogene 2001, 20:8270-8275.
54. Dey A., Nishiyama A., Karpova T., McNally J., Ozato K. Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription. Mol. Biol. Cell 2009, 20:4899-4909.
55. Dominguez-Sola D., et al. Non-transcriptional control of DNA replication by c-Myc. Nature 2007, 448:445-451.
56. Duncan J.S., et al. A peptide-based target screen implicates the protein kinase CK2 in the global regulation of caspase signaling. Sci. Signal. 2011, 4:ra30.
57. Eberhardy S.R., Farnham P.J. c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism. J. Biol. Chem. 2001, 276:48562-48571.
58. Eberhardy S.R., Farnham P.J. Myc recruits P-TEFb to mediate the final step in the transcriptional activation of the cad promoter. J. Biol. Chem. 2002, 277:40156-40162.
59. Eberhardy S.R., D'Cunha C.A., Farnham P.J. Direct examination of histone acetylation on Myc target genes using chromatin immunoprecipitation. J. Biol. Chem. 2000, 275:33798-33805.
60. Eilers M., Eisenman R.N. Myc's broad reach. Genes Dev. 2008, 22:2755-2766.
61. Faiola F., et al. Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription. Mol. Cell. Biol. 2005, 25:10220-10234.
62. Faiola F., Wu Y.T., Pan S., Zhang K., Farina A., Martinez E. Max is acetylated by p300 at several nuclear localization residues. Biochem. J. 2007, 403:397-407.
63. Fan J., et al. Time-dependent c-Myc transactomes mapped by Array-based nuclear run-on reveal transcriptional modules in human B cells. PLoS One 2010, 5:e9691.
64. Feng X.H., Liang Y.Y., Liang M., Zhai W., Lin X. Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-beta-mediated induction of the CDK inhibitor p15(Ink4B). Molecular cell. 2002, 9:133-143.
65. Fernandez P.C., et al. Genomic targets of the human c-Myc protein. Genes Dev. 2003, 17:1115-1129.
66. Fox C.J., Hammerman P.S., Cinalli R.M., Master S.R., Chodosh L.A., Thompson C.B. The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor. Genes Dev. 2003, 17:1841-1854.
67. Frank S.R., Schroeder M., Fernandez P., Taubert S., Amati B. Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev. 2001, 15:2069-2082.
68. Frank S.R., et al. MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep. 2003, 4:575-580.
69. Frescas D., Pagano M. Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat. Rev. Cancer 2008, 8:438-449.
70. Frye M., Fisher A.G., Watt F.M. Epidermal stem cells are defined by global histone modifications that are altered by Myc-induced differentiation. PLoS One 2007, 2:e763.
71. Fuchs M., et al. The p400 complex is an essential E1A transformation target. Cell 2001, 106:297-307.
72. Fujii M., et al. SNIP1 is a candidate modifier of the transcriptional activity of c-Myc on E box-dependent target genes. Molecular cell. 2006, 24:771-783.
73. Garcia-Bassets I., et al. Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 2007, 128:505-518.
74. Gargano B., Amente S., Majello B., Lania L. P-TEFb is a crucial co-factor for Myc transactivation. Cell Cycle 2007, 6:2031-2037.
75. Gartel A.L., et al. Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:4510-4515.
76. Ge Z., et al. Chromatin remodeling: recruitment of histone demethylase RBP2 by Mad1 for transcriptional repression of a Myc target gene, telomerase reverse transcriptase. FASEB J. 2010, 24:579-586.
77. Gevry N., Chan H.M., Laflamme L., Livingston D.M., Gaudreau L. p21 transcription is regulated by differential localization of histone H2A.Z. Genes Dev. 2007, 21:1869-1881.
78. Gomez-Roman N., Grandori C., Eisenman R.N., White R.J. Direct activation of RNA polymerase III transcription by c-Myc. Nature 2003, 421:290-294.
79. Gordan J.D., Bertout J.A., Hu C.J., Diehl J.A., Simon M.C. HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell. 2007, 11:335-347.
80. Gordon S., Akopyan G., Garban H., Bonavida B. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene 2006, 25:1125-1142.
81. Grabbe C., Husnjak K., Dikic I. The spatial and temporal organization of ubiquitin networks. Nat. Rev. Mol. Cell Biol. 2011, 12:295-307.
82. Grandori C., Cowley S.M., James L.P., Eisenman R.N. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 2000, 16:653-699.
83. Grandori C., et al. c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat Cell Biol. 2005, 7:311-318.
84. Grant P.A., Schieltz D., Pray-Grant M.G., Yates J.R., Workman J.L. The ATM-related cofactor Tra1 is a component of the purified SAGA complex. Molecular cell. 1998, 2:863-867.
85. Greene L.A., Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. U. S. A. 1976, 73:2424-2428.
86. Grewal S.S., Li L., Orian A., Eisenman R.N., Edgar B.A. Myc-dependent regulation of ribosomal RNA synthesis during Drosophila development. Nat Cell Biol. 2005, 7:295-302.
87. Grim J.E., et al. Isoform- and cell cycle-dependent substrate degradation by the Fbw7 ubiquitin ligase. The Journal of cell biology. 2008, 181:913-920.
88. Gronroos E., Hellman U., Heldin C.H., Ericsson J. Control of Smad7 stability by competition between acetylation and ubiquitination. Molecular cell. 2002, 10:483-493.
89. Guccione E., et al. Myc-binding-site recognition in the human genome is determined by chromatin context. Nature cell biology. 2006, 8:764-770.
90. Haigis M.C., Sinclair D.A. Mammalian sirtuins: biological insights and disease relevance. Annu. Rev. Pathol. 2010, 5:253-295.
91. Hart G.W., Housley M.P., Slawson C. Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 2007, 446:1017-1022.
92. Henriksson M., Lüscher B. Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res. 1996, 68:109-182.
93. Herceg Z., et al. Disruption of Trrap causes early embryonic lethality and defects in cell cycle progression. Nat. Genet. 2001, 29:206-211.
94. Herkert B., Eilers M. Transcriptional repression: the dark side of myc. Genes & cancer. 2010, 1:580-586.
95. Hishida T., et al. Indefinite self-renewal of ESCs through Myc/Max transcriptional complex-independent mechanisms. Cell Stem Cell 2011, 9:37-49.
96. Hochheimer A., Tjian R. Diversified transcription initiation complexes expand promoter selectivity and tissue-specific gene expression. Genes Dev. 2003, 17:1309-1320.
97. Hopewell R., Ziff E.B. The nerve growth factor-responsive PC12 cell line does not express the Myc dimerization partner Max. Mol. Cell. Biol. 1995, 15:3470-3478.
98. Huang Z., Traugh J.A., Bishop J.M. Negative control of the Myc protein by the stress-responsive kinase Pak2. Mol. Cell. Biol. 2004, 24:1582-1594.
99. Hurlin P.J. N-Myc functions in transcription and development. Birth defects research. Part C. Embryo Today 2005, 75:340-352.
100. Hydbring P., et al. Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:58-63.
101. Iritani B.M., Eisenman R.N. c-Myc enhances protein synthesis and cell size during B lymphocyte development. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:13180-13185.
102. Jang M.K., Mochizuki K., Zhou M., Jeong H.S., Brady J.N., Ozato K. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol. Cell 2005, 19:523-534.
103. Jiang G., Espeseth A., Hazuda D.J., Margolis D.M. c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter. J. Virol. 2007, 81:10914-10923.
104. Johnston L.A., Prober D.A., Edgar B.A., Eisenman R.N., Gallant P. Drosophila Myc regulates cellular growth during development. Cell 1999, 98:779-790.
105. Kalashnikova E.V., et al. ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2. Cancer Res. 2010, 70:9402-9412.
106. Kanazawa S., Soucek L., Evan G., Okamoto T., Peterlin B.M. c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosis. Oncogene 2003, 22:5707-5711.
107. Kenneth N.S., Ramsbottom B.A., Gomez-Roman N., Marshall L., Cole P.A., White R.J. TRRAP and GCN5 are used by c-Myc to activate RNA polymerase III transcription. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:14917-14922.
108. Kidder B.L., Yang J., Palmer S. Stat3 and c-Myc genome-wide promoter occupancy in embryonic stem cells. PLoS One 2008, 3:e3932.
109. Kim R.H., et al. A novel smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-beta signal transduction. Genes Dev. 2000, 14:1605-1616.
110. Kim R.H., et al. SNIP1 inhibits NF-kappa B signaling by competing for its binding to the C/H1 domain of CBP/p300 transcriptional co-activators. J. Biol. Chem. 2001, 276:46297-46304.
111. Kim S.Y., Herbst A., Tworkowski K.A., Salghetti S.E., Tansey W.P. Skp2 regulates Myc protein stability and activity. Mol Cell. 2003, 11:1177-1188.
112. Kim J.W., Gao P., Liu Y.C., Semenza G.L., Dang C.V. Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol. Cell. Biol. 2007, 27:7381-7393.
113. Kim J., Chu J., Shen X., Wang J., Orkin S.H. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 2008, 132:1049-1061.
114. Kim J., Lee J.H., Iyer V.R. Global identification of Myc target genes reveals its direct role in mitochondrial biogenesis and its E-box usage in vivo. PLoS One 2008, 3:e1798.
115. Kim J., et al. A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Cell 2010, 143:313-324.
116. Knoepfler P.S., Zhang X.Y., Cheng P.F., Gafken P.R., McMahon S.B., Eisenman R.N. Myc influences global chromatin structure. EMBO J. 2006, 25:2723-2734.
117. Koch H.B., et al. Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. Cell Cycle. 2007, 6:205-217.
118. Kodadek T., Sikder D., Nalley K. Keeping transcriptional activators under control. Cell 2006, 127:261-264.
119. Koppenol W.H., Bounds P.L., Dang C.V. Otto Warburg's contributions to current concepts of cancer metabolism. Nat. Rev. Cancer 2011, 11:325-337.
120. Koshiji M., Kageyama Y., Pete E.A., Horikawa I., Barrett J.C., Huang L.E. HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. EMBO J. 2004, 23:1949-1956.
121. Koskinen P.J., Vastrik I., Makela T.P., Eisenman R.N., Alitalo K. Max activity is affected by phosphorylation at two NH2-terminal sites. Cell growth & differentiation: the molecular biology. J. Am. Assoc. Cancer Res. 1994, 5:313-320.
122. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
123. Krippner-Heidenreich A., et al. Targeting of the transcription factor Max during apoptosis: phosphorylation-regulated cleavage by caspase-5 at an unusual glutamic acid residue in position P1. Biochem. J. 2001, 358:705-715.
124. Kurland J.F., Tansey W.P. Myc-mediated transcriptional repression by recruitment of histone deacetylase. Cancer Res. 2008, 68:3624-3629.
125. Kurosu T., Peterlin B.M. VP16 and ubiquitin; binding of P-TEFb via its activation domain and ubiquitin facilitates elongation of transcription of target genes. Curr. Biol. 2004, 14:1112-1116.
126. Laherty C.D., Yang W.M., Sun J.M., Davie J.R., Seto E., Eisenman R.N. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 1997, 89:349-356.
127. Lan F., Nottke A.C., Shi Y. Mechanisms involved in the regulation of histone lysine demethylases. Curr. Opin. Cell Biol. 2008, 20:316-325.
128. Lee S.B., et al. Romo1 is a negative-feedback regulator of Myc. J. Cell Sci. 2011, 124:1911-1924.
129. Li M., Luo J., Brooks C.L., Gu W. Acetylation of p53 inhibits its ubiquitination by Mdm2. J. Biol. Chem. 2002, 277:50607-50611.
130. Li Z., Van Calcar S., Qu C., Cavenee W.K., Zhang M.Q., Ren B. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:8164-8169.
131. Li, H., Wittwer, T., Weber, A., Schneider, H., Moreno, R., Maine, G.N., Kracht, M., Schmitz, M.L., Burstein, E., in press. Regulation of NF-κB activity by competition between RelA acetylation and ubiquitination. Oncogene 2011 Jun 27 (Electronic publication ahead of print]). doi:. doi:10.1038/onc.2011.253.
132. Liu J., Levens D. Making Myc. Curr. Top. Microbiol. Immunol. 2006, 302:1-32.
133. Liu C., et al. The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3. Cancer Res. 2007, 67:2626-2631.
134. Liu J., Martin H.J., Liao G., Hayward S.D. The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc. J. Virol. 2007, 81:10451-10459.
135. Liu T., et al. Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:18682-18687.
136. Liu X., Vorontchikhina M., Wang Y.L., Faiola F., Martinez E. STAGA recruits mediator to the MYC oncoprotein to stimulate transcription and cell proliferation. Mol. Cell. Biol. 2008, 28:108-121.
137. Liu Y.C., et al. Global regulation of nucleotide biosynthetic genes by c-Myc. PLoS One 2008, 3:e2722.
138. Lüscher B. Function and regulation of the transcription factors of the Myc/Max/Mad network. Gene 2001, 277:1-14.
139. Lüscher, B., in press. MAD1 and its life as a MYC antagonist: An update. Eur J Cell Biol. 2011 Sep 12. (Electronic publication ahead of print).
140. Lüscher B., Eisenman R.N. Mitosis-specific phosphorylation of the nuclear oncoproteins Myc and Myb. The Journal of cell biology. 1992, 118:775-784.
141. Lüscher B., Larsson L.G. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation. Oncogene 1999, 18:2955-2966.
142. Lüscher B., Kuenzel E.A., Krebs E.G., Eisenman R.N. Myc oncoproteins are phosphorylated by casein kinase II. EMBO J. 1989, 8:1111-1119.
143. Mao D.Y., et al. Analysis of Myc bound loci identified by CpG island arrays shows that Max is essential for Myc-dependent repression. Current biology : CB. 2003, 13:882-886.
144. Mao B., et al. Sirt1 deacetylates c-Myc and promotes c-Myc/Max association. Int. J. Biochem. Cell Biol. 2011, 43:1573-1581.
145. Marques M., Laflamme L., Gervais A.L., Gaudreau L. Reconciling the positive and negative roles of histone H2A.Z in gene transcription. Epigenetics 2010, 5:267-272.
146. Marshall G.M., et al. SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stability. PLoS Genet. 2011, 7:e1002135.
147. Martinato F., Cesaroni M., Amati B., Guccione E. Analysis of Myc-induced histone modifications on target chromatin. PLoS One 2008, 3:e3650.
148. Matheu A., Maraver A., Serrano M. The Arf/p53 pathway in cancer and aging. Cancer Res. 2008, 68:6031-6034.
149. McMahon S.B., Van Buskirk H.A., Dugan K.A., Copeland T.D., Cole M.D. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 1998, 94:363-374.
150. McMahon S.B., Wood M.A., Cole M.D. The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc. Mol. Cell. Biol. 2000, 20:556-562.
151. Medina P.P., et al. Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines. Hum. Mutat. 2008, 29:617-622.
152. Menssen A., Hermeking H. Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:6274-6279.
153. Menssen, A., Hydbring, P., Kapelle, K., Vervoorts, J., Diebold, J., Lüscher, B., Larsson, L.G., Hermeking, H., in press. The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop. Proc. Natl. Acad. Sci. U. S. A. 2011 Dec 21 (Electronic publication ahead of print).
154. Moore J.P., Hancock D.C., Littlewood T.D., Evan G.I. A sensitive and quantitative enzyme-linked immunosorbence assay for the c-myc and N-myc oncoproteins. Oncogene Res. 1987, 2:65-80.
155. Murr R., Vaissiere T., Sawan C., Shukla V., Herceg Z. Orchestration of chromatin-based processes: mind the TRRAP. Oncogene 2007, 26:5358-5372.
156. Musgrove E.A., et al. Identification of functional networks of estrogen- and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer. PLoS One 2008, 3:e2987.
157. Nagy Z., Tora L. Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation. Oncogene 2007, 26:5341-5357.
158. Nakayama K.I., Nakayama K. Ubiquitin ligases: cell-cycle control and cancer. Nat. Rev. Cancer 2006, 6:369-381.
159. Nowak S.J., Corces V.G. Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Trends Genet. 2004, 20:214-220.
160. O'Connell B.C., et al. A large scale genetic analysis of c-Myc-regulated gene expression patterns. J. Biol. Chem. 2003, 278:12563-12573.
161. O'Hagan R.C., et al. Gene-target recognition among members of the myc superfamily and implications for oncogenesis. Nat. Genet. 2000, 24:113-119.
162. O'Neil J., et al. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J. Exp. Med. 2007, 204:1813-1824.
163. Onoyama I., et al. Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis. The Journal of experimental medicine. 2007, 204:2875-2888.
164. Orian A., Eisenman R.N. TGF-beta flips the Myc switch. Science's STKE: signal transduction knowledge environment. 2001, pe1 2001.
165. Orian A., et al. Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network. Genes Dev. 2003, 17:1101-1114.
166. Otto T., et al. Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma. Cancer Cell. 2009, 15:67-78.
167. Ouyang Z., Zhou Q., Wong W.H. ChIP-Seq of transcription factors predicts absolute and differential gene expression in embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:21521-21526.
168. Pajic A., et al. Cell cycle activation by c-myc in a Burkitt lymphoma model cell line. Int. J. Cancer 2000, 87:787-793.
169. Pal S., et al. mSin3A/histone deacetylase 2- and PRMT5-containing Brg1 complex is involved in transcriptional repression of the Myc target gene cad. Mol. Cell. Biol. 2003, 23:7475-7487.
170. Park J., Kunjibettu S., McMahon S.B., Cole M.D. The ATM-related domain of TRRAP is required for histone acetyltransferase recruitment and Myc-dependent oncogenesis. Genes Dev. 2001, 15:1619-1624.
171. Park J., Wood M.A., Cole M.D. BAF53 forms distinct nuclear complexes and functions as a critical c-Myc-interacting nuclear cofactor for oncogenic transformation. Mol. Cell. Biol. 2002, 22:1307-1316.
172. Patel J.H., et al. The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60. Mol. Cell. Biol. 2004, 24:10826-10834.
173. Pawlicki J.M., Steitz J.A. Nuclear networking fashions pre-messenger RNA and primary microRNA transcripts for function. Trends Cell Biol. 2010, 20:52-61.
174. Perillo B., et al. DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression. Science 2008, 319:202-206.
175. Perissi V., Rosenfeld M.G. Controlling nuclear receptors: the circular logic of cofactor cycles. Nat. Rev. Mol. Cell Biol. 2005, 6:542-554.
176. Perna, D., Fagà, G., Verrecchia, A., Gorski, M.M., Barozzi, I., Narang, V., Khng, J., Lim, K.C., Sung, W.K., Sanges, R., Stupka, E., Oskarsson, T., Trumpp, A., Wei, C.L., Müller, H., Amati, B., in press. Genome-wide mapping of Myc binding and gene regulation in serum-stimulated fibroblasts. Oncogene [Electronic publication ahead of print].
177. Peukert K., Staller P., Schneider A., Carmichael G., Hanel F., Eilers M. An alternative pathway for gene regulation by Myc. EMBO J. 1997, 16:5672-5686.
178. Pierce S.B., Yost C., Anderson S.A., Flynn E.M., Delrow J., Eisenman R.N. Drosophila growth and development in the absence of dMyc and dMnt. Dev. Biol. 2008, 315:303-316.
179. Popov N., Schulein C., Jaenicke L.A., Eilers M. Ubiquitylation of the amino terminus of Myc by SCF(beta-TrCP) antagonizes SCF(Fbw7)-mediated turnover. Nature cell biology. 2010, 12:973-981.
180. Prendergast G.C., Lawe D., Ziff E.B. Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell 1991, 65:395-407.
181. Qi Y., Gregory M.A., Li Z., Brousal J.P., West K., Hann S.R. p19ARF directly and differentially controls the functions of c-Myc independently of p53. Nature 2004, 431:712-717.
182. Rahl P.B., et al. c-Myc regulates transcriptional pause release. Cell 2010, 141:432-445.
183. Reisman D., Glaros S., Thompson E.A. The SWI/SNF complex and cancer. Oncogene 2009, 28:1653-1668.
184. Ribon V., Leff T., Saltiel A.R. c-Myc does not require max for transcriptional activity in PC-12 cells. Mol. Cell. Neurosci. 1994, 5:277-282.
185. Roeder R.G. Transcriptional regulation and the role of diverse coactivators in animal cells. FEBS Lett. 2005, 579:909-915.
186. Rottmann S., Lüscher B. The mad side of the Max network: antagonizing the function of Myc and more. Curr. Top. Microbiol. Immunol. 2006, 302:63-122.
187. Rottmann S., et al. Mad1 function in cell proliferation and transcriptional repression is antagonized by cyclin E/CDK2. J. Biol. Chem. 2005, 280:15489-15492.
188. Saleh A., et al. Tra1p is a component of the yeast Ada. Spt transcriptional regulatory complexes. J. Biol. Chem. 1998, 273:26559-26565.
189. Salghetti S.E., Muratani M., Wijnen H., Futcher B., Tansey W.P. Functional overlap of sequences that activate transcription and signal ubiquitin-mediated proteolysis. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:3118-3123.
190. Salghetti S.E., Caudy A.A., Chenoweth J.G., Tansey W.P. Regulation of transcriptional activation domain function by ubiquitin. Science 2001, 293:1651-1653.
191. Satou A., Taira T., Iguchi-Ariga S.M., Ariga H. A novel transrepression pathway of c-Myc. Recruitment of a transcriptional corepressor complex to c-Myc by MM-1, a c-Myc-binding protein. J. Biol. Chem. 2001, 276:46562-46567.
192. Schlosser I., et al. Dissection of transcriptional programmes in response to serum and c-Myc in a human B-cell line. Oncogene 2005, 24:520-524.
193. Schuhmacher M., et al. Control of cell growth by c-Myc in the absence of cell division. Current biology : CB. 1999, 9:1255-1258.
194. Schuhmacher M., et al. The transcriptional program of a human B cell line in response to Myc. Nucleic Acids Res. 2001, 29:397-406.
195. Schuldiner O., Benvenisty N. A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors. Oncogene 2001, 20:4984-4994.
196. Secombe J., Li L., Carlos L., Eisenman R.N. The Trithorax group protein Lid is a trimethyl histone H3K4 demethylase required for dMyc-induced cell growth. Genes Dev. 2007, 21:537-551.
197. Seitz V., et al. Deep sequencing of MYC DNA-binding sites in Burkitt lymphoma. PLoS One 2011, 6:e26837.
198. Shen-Li H., O'Hagan R.C., Hou H., Horner J.W., Lee H.W., DePinho R.A. Essential role for Max in early embryonic growth and development. Genes Dev. 2000, 14:17-22.
199. Shrivastava A., Saleque S., Kalpana G.V., Artandi S., Goff S.P., Calame K. Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. Science 1993, 262:1889-1892.
200. Smith K., Dalton S. Myc transcription factors: key regulators behind establishment and maintenance of pluripotency. Regen. Med. 2010, 5:947-959.
201. Smith A.P., et al. A positive role for Myc in TGFbeta-induced Snail transcription and epithelial-to-mesenchymal transition. Oncogene 2009, 28:422-430.
202. Sommer A., et al. Cell growth inhibition by the Mad/Max complex through recruitment of histone deacetylase activity. Current biology : CB. 1997, 7:357-365.
203. Staller P., et al. Repression of p15INK4b expression by Myc through association with Miz-1. Nat Cell Biol. 2001, 3:392-399.
204. Steiger D., Furrer M., Schwinkendorf D., Gallant P. Max-independent functions of Myc in Drosophila melanogaster. Nat. Genet. 2008, 40:1084-1091.
205. Takayama M.A., Taira T., Tamai K., Iguchi-Ariga S.M., Ariga H. ORC1 interacts with c-Myc to inhibit E-box-dependent transcription by abrogating c-Myc-SNF5/INI1 interaction. Genes Cells 2000, 5:481-490.
206. Tan M., et al. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell 2011, 146:1016-1028.
207. Thomas L.R., Tansey W.P. Proteolytic control of the oncoprotein transcription factor Myc. Adv. Cancer Res. 2011, 110:77-106.
208. Thompson B.J., et al. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. The Journal of experimental medicine. 2007, 204:1825-1835.
209. Uribesalgo I., et al. E-box-independent regulation of transcription and differentiation by MYC. Nat. Cell Biol. 2011, 13:1443-1449.
210. van der Lugt N.M., et al. Proviral tagging in E mu-myc transgenic mice lacking the Pim-1 proto-oncogene leads to compensatory activation of Pim-2. EMBO J. 1995, 14:2536-2544.
211. van Lohuizen M., Verbeek S., Scheijen B., Wientjens E., van der Gulden H., Berns A. Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell 1991, 65:737-752.
212. Varlakhanova N.V., Knoepfler P.S. Acting locally and globally: Myc's ever-expanding roles on chromatin. Cancer Res. 2009, 69:7487-7490.
213. Vassilev A., et al. The 400kDa subunit of the PCAF histone acetylase complex belongs to the ATM superfamily. Molecular cell. 1998, 2:869-875.
214. Vervoorts J., et al. Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. EMBO Rep. 2003, 4:484-490.
215. Vervoorts J., Luscher-Firzlaff J., Lüscher B. The ins and outs of MYC regulation by posttranslational mechanisms. J. Biol. Chem. 2006, 281:34725-34729.
216. von der Lehr N., et al. The F-Box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol Cell. 2003, 11:1189-1200.
217. Warburg O. Über den Stoffwechsel der Carcinomzelle. Klin. Wochenschr. 1925, 4:534-536.
218. Welcker M., Clurman B.E. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat. Rev. Cancer 2008, 8:83-93.
219. Welcker M., Orian A., Grim J.E., Eisenman R.N., Clurman B.E. A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size. Current biology : CB. 2004, 14:1852-1857.
220. Welcker M., et al. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:9085-9090.
221. Wendel H.G., et al. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 2004, 428:332-337.
222. White R.J. RNA polymerases I and III, non-coding RNAs and cancer. Trends in genetics : TIG. 2008, 24:622-629.
223. Wu S.Y., Chiang C.M. The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation. J. Biol. Chem. 2007, 282:13141-13145.
224. Xu D., et al. Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:3826-3831.
225. Yada M., et al. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J. 2004, 23:2116-2125.
226. Yanagisawa J., et al. Nuclear receptor function requires a TFTC-type histone acetyl transferase complex. Molecular cell. 2002, 9:553-562.
227. Yang Z., et al. Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol Cell. 2005, 19:535-545.
228. Yang Z., He N., Zhou Q. Brd4 recruits P-TEFb to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression. Mol. Cell. Biol. 2008, 28:967-976.
229. Yap C.S., Peterson A.L., Castellani G., Sedivy J.M., Neretti N. Kinetic profiling of the c-Myc transcriptome and bioinformatic analysis of repressed gene promoters. Cell Cycle. 2011, 10:2184-2196.
230. Yatabe N., et al. HIF-1-mediated activation of telomerase in cervical cancer cells. Oncogene 2004, 23:3708-3715.
231. Ying Q.L., et al. The ground state of embryonic stem cell self-renewal. Nature 2008, 453:519-523.
232. Yuan J., Minter-Dykhouse K., Lou Z. A c-Myc-SIRT1 feedback loop regulates cell growth and transformation. The Journal of cell biology. 2009, 185:203-211.
233. Zeller K.I., et al. Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:17834-17839.
234. Zhang K., Faiola F., Martinez E. Six lysine residues on c-Myc are direct substrates for acetylation by p300. Biochem. Biophys. Res. Commun. 2005, 336:274-280.
235. Zhao X., et al. The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein. Nature cell biology. 2008, 10:643-653.
236. Zippo A., De Robertis A., Serafini R., Oliviero S. PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation. Nature cell biology. 2007, 9:932-944.
237. Zippo A., Serafini R., Rocchigiani M., Pennacchini S., Krepelova A., Oliviero S. Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation. Cell 2009, 138:1122-1136.
238. Zuber J., et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 2011, 478:524-528.
239. Zurita M., Merino C. The transcriptional complexity of the TFIIH complex. Trends in genetics: TIG. 2003, 19:578-584.